We are live on ! Find out more
Holocene Advisors

Holocene Advisors Portfolio holdings

AUM $41.5B
1-Year Est. Return 42.97%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+42.97%
3 Year Est. Return
+132.57%
5 Year Est. Return
+195.68%
10 Year Est. Return
AUM
$43.9B
AUM Growth
+$2.91B
Cap. Flow
-$439M
Cap. Flow %
-1%
Top 10 Hldgs %
30.12%
Holding
939
New
200
Increased
225
Reduced
301
Closed
207

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.24B
2
TSLA icon
Tesla
TSLA
+$1.22B
3
V icon
Visa
V
+$648M
4
JPM icon
JPMorgan Chase
JPM
+$584M
5
META icon
Meta Platforms (Facebook)
META
+$397M

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Consumer Discretionary 23.39%
3 Healthcare 13.38%
4 Financials 9.66%
5 Industrials 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
126
CALL
Caterpillar
CAT
$409B
$85.9M 0.2%
+180,000
New +$76.8M
REGN icon
127
Regeneron Pharmaceuticals
REGN
$68.8B
$85.3M 0.19%
+151,733
New +$85.8M
PANW icon
128
Palo Alto Networks
PANW
$264B
$84.6M 0.19%
+415,570
New +$79.6M
CDNS icon
129
Cadence Design Systems
CDNS
$90B
$83.4M 0.19%
237,480
+15,650
+7% +$5.38M
APP icon
130
Applovin
APP
$132B
$83.3M 0.19%
115,882
+59,608
+106% +$27.5M
IRTC icon
131
iRhythm Holdings
IRTC
$3.59B
$81.4M 0.19%
473,280
+160,186
+51% +$25.5M
KKR icon
132
KKR & Co
KKR
$89.2B
$80.2M 0.18%
616,843
-197,678
-24% -$28.1M
CRWV
133
CoreWeave
CRWV
$39.2B
$79.8M 0.18%
+583,075
New +$69M
JAZZ icon
134
Jazz Pharmaceuticals
JAZZ
$15.9B
$79.8M 0.18%
605,109
+135,367
+29% +$16.2M
XENE icon
135
Xenon Pharmaceuticals
XENE
$6.32B
$79.4M 0.18%
1,976,553
+167,078
+9% +$5.88M
PEN icon
136
Penumbra
PEN
$12.5B
$78.6M 0.18%
+310,219
New +$78.2M
KMI icon
137
Kinder Morgan
KMI
$73.1B
$77.7M 0.18%
+2,743,279
New +$75.1M
XPO icon
138
CALL
XPO
XPO
$25B
$77.6M 0.18%
+600,000
New +$77.9M
SCHW
139
Charles Schwab
SCHW
$177B
$76.7M 0.17%
803,609
-744,226
-48% -$70.6M
NUE icon
140
Nucor
NUE
$56.4B
$74.3M 0.17%
548,911
+326,572
+147% +$46.2M
ALKS icon
141
Alkermes
ALKS
$8.82B
$74.1M 0.17%
2,469,030
-384,738
-13% -$10.8M
UHS icon
142
Universal Health Services
UHS
$9.43B
$73.4M 0.17%
358,885
+259,861
+262% +$46.8M
SLB icon
143
SLB Ltd
SLB
$77.8B
$72.6M 0.17%
+2,112,378
New +$73.5M
CME icon
144
CME Group
CME
$92.2B
$72.6M 0.17%
+268,588
New +$73.1M
MS icon
145
Morgan Stanley
MS
$337B
$72.1M 0.16%
453,461
+449,677
+11,884% +$66.4M
NU icon
146
Nu Holdings
NU
$68.1B
$68.8M 0.16%
4,300,000
ICLR icon
147
Icon
ICLR
$12.8B
$68.7M 0.16%
392,506
-287,221
-42% -$48.1M
AVTR icon
148
Avantor
AVTR
$7.81B
$68.6M 0.16%
5,493,677
+4,040,154
+278% +$52.1M
SLNO
149
DELISTED
Soleno Therapeutics
SLNO
$67.4M 0.15%
997,069
-155,979
-14% -$11.6M
RRC icon
150
Range Resources
RRC
$9.11B
$66.6M 0.15%
+1,768,330
New +$63.2M

Similar funds

Holocene Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Holocene Advisors held 939 positions worth $43.9B, up 7.1% from $41B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Holocene Advisors's Q3 2025 filing shows 200 new, 225 increased, 301 reduced and 207 closed positions. Its largest new stake was Ross Stores: 2,308,305 shares worth $352M. The largest sale was Alphabet (Google) Class A, an estimated $1.39B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Holocene Advisors's largest Q3 2025 buy was Ross Stores: 2,308,305 shares worth $352M.
  • Holocene Advisors added most to NVIDIA in Q3 2025, an estimated $1.24B increase.
  • Holocene Advisors's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $1.39B.
  • Holocene Advisors fully exited iShares Russell 2000 ETF in Q3 2025, selling an estimated $1.23B.
  • Holocene Advisors's ten largest holdings make up 30% of its $43.9B portfolio in Q3 2025.
  • Holocene Advisors opened 200 new positions and closed 207 in Q3 2025.
  • Holocene Advisors's portfolio value rose 7.1% quarter-over-quarter to $43.9B.

Based on Holocene Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.